Randomized Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
Conditions: Dyslipidemias; Hypercholesterolemia; Familial Hypercholesterolemia; ASCVD; High Cholesterol Interventions: Combination Product: Combination Therapy; Drug: Monotherapy obicetrapib; Drug: Monotherapy ezetimibe; Other: Combination Therapy placebo; Other: Obicetrapib Placebo; Other: Ezetimibe Placebo Sponsor: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Daily Blood Glucose Trends in Patients at Risk for Diabetes
Conditions: Stress; Blood Sugar; High; Cholesterol, Elevated; Diet Habit Intervention: Device: 7-Day Continuous Glucose Monitoring with Abbott Freestyle Libre 2 Sponsors: Karol E. Watson, MD; University of California, Los Angeles Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
